Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding
- PMID: 9241305
- DOI: 10.1016/S0029-7844(97)00226-3
Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding
Abstract
Objective: To compare the effect of a levonorgestrel-releasing intrauterine device with that of endometrial resection on menstrual bleeding, patient satisfaction, and quality of life in menorrhagic women during 12 months of follow-up.
Methods: Seventy premenopausal women with dysfunctional uterine bleeding were enrolled in a prospective, open, parallel-group, controlled trial. They were randomized to either insertion of an intrauterine system releasing 20 micrograms/day of levonorgestrel (n = 35) or endometrial resection (n = 35). The women were evaluated at baseline, and thereafter, uterine bleeding was assessed monthly with a pictorial blood loss assessment chart. Clinical gynecologic examination was performed bimonthly, and the hematologic variables were measured at 6 and 12 months. On the latter occasion, the women were requested to rate the degree of satisfaction with the effect of their treatment and to complete the Short Form 36 General Health Survey questionnaire.
Results: Recurrent menorrhagia was observed at 12 months in four women in the intrauterine device group (including two with partial expulsion of the device) and in three women in the resection group. Compared with baseline values, at 1 year, the pictorial blood loss assessment chart score was reduced by 79% in the former group and by 89% in the latter. Amenorrhea or hypomenorrhea at 12 months was reported by 65% of the women with an intrauterine device compared with 71% who underwent endometrial resection. The degree of satisfaction with treatment was high in both groups, with 29 of 34 (85%) women being satisfied or very satisfied in the intrauterine device group versus 33 of 35 (94%) in the resection group. Health-related quality of life perception was not significantly different in the two treatment groups.
Conclusion: Somewhat less satisfactory results were obtained with a levonorgestrel-releasing intrauterine system compared with endometrial resection for dysfunctional uterine bleeding at 1 year of follow-up.
Similar articles
-
Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.Eur J Contracept Reprod Health Care. 2001 Jun;6(2):93-101. Eur J Contracept Reprod Health Care. 2001. PMID: 11518454
-
[The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].Minerva Ginecol. 2002 Jun;54(3):271-8. Minerva Ginecol. 2002. PMID: 12063443 Italian.
-
Current treatment of dysfunctional uterine bleeding.Maturitas. 2004 Mar 15;47(3):159-74. doi: 10.1016/j.maturitas.2003.08.002. Maturitas. 2004. PMID: 15036486 Review.
-
Long-term treatment of menorrhagia with levonorgestrel intrauterine system versus endometrial resection.Obstet Gynecol. 2004 Dec;104(6):1314-21. doi: 10.1097/01.AOG.0000143824.16435.91. Obstet Gynecol. 2004. PMID: 15572496 Clinical Trial.
-
Progestin-releasing intrauterine systems.Semin Reprod Med. 2001 Dec;19(4):355-63. doi: 10.1055/s-2001-18643. Semin Reprod Med. 2001. PMID: 11727177 Review.
Cited by
-
Abnormal uterine bleeding: a review of patient-based outcome measures.Fertil Steril. 2009 Jul;92(1):205-16. doi: 10.1016/j.fertnstert.2008.04.023. Epub 2008 Jul 16. Fertil Steril. 2009. PMID: 18635169 Free PMC article.
-
Abnormal uterine bleeding in midlife: The role of levonorgestrel intrauterine system.J Midlife Health. 2013 Jan;4(1):36-9. doi: 10.4103/0976-7800.109634. J Midlife Health. 2013. PMID: 23833532 Free PMC article.
-
Recent developments in hormonal contraception.Rev Endocr Metab Disord. 2002 Sep;3(3):257-65. doi: 10.1023/a:1020080627635. Rev Endocr Metab Disord. 2002. PMID: 12215720 Review. No abstract available.
-
Interventions for heavy menstrual bleeding; overview of Cochrane reviews and network meta-analysis.Cochrane Database Syst Rev. 2022 May 31;5(5):CD013180. doi: 10.1002/14651858.CD013180.pub2. Cochrane Database Syst Rev. 2022. PMID: 35638592 Free PMC article.
-
Benefit-risk assessment of the levonorgestrel intrauterine system in contraception.Drug Saf. 2004;27(15):1185-204. doi: 10.2165/00002018-200427150-00003. Drug Saf. 2004. PMID: 15588115
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources